Results 1 to 10 of about 1,360,274 (268)

Population-Based Screening of Newborns: Findings From the NBS Expansion Study (Part One)

open access: yesFrontiers in Genetics, 2022
Each year, through population-based newborn screening (NBS), 1 in 294 newborns is identified with a condition leading to early treatment and, in some cases, life-saving interventions.
Amy Brower   +26 more
doaj   +6 more sources

Perspective on newborn screening (NBS): Evidence sharing on conditions to be included in NBS in Pakistan.

open access: yesJournal of the Pakistan Medical Association, 2022
Newborn screening aims at detecting treatable disorders early so that the treatment can be initiated to prevent mortality and morbidity. Such programmes are well established in most developed countries, and all newborns are screened for selected ...
Hafsa Majid   +8 more
semanticscholar   +3 more sources

Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures

open access: yesInternational Journal of Neonatal Screening, 2023
Newborn screening using dried blood spots (NBS) is widely acknowledged as a highly successful procedure in secondary prevention. For a number of congenital disorders, severe disability or death are impressively prevented by early detection and early ...
Birgit Odenwald   +4 more
semanticscholar   +4 more sources

Case Report of Argininemia: The Utility of the Arginine/Ornithine Ratio for Newborn Screening (NBS). [PDF]

open access: yesJIMD Reports, 2013
We describe a case of Argininemia detected by Michigan Newborn Screening (NBS). The Secretary's Advisory Committee on Heritable Disorders in Newborns and Children recommends that every MS/MS newborn screening program include Argininemia as part of their uniform screening panel.
A. Jay   +3 more
semanticscholar   +3 more sources

NBSTRN Tools to Advance Newborn Screening Research and Support Newborn Screening Stakeholders

open access: yesInternational Journal of Neonatal Screening, 2023
Rapid advances in the screening, diagnosis, and treatment of genetic disorders have increased the number of conditions that can be detected through universal newborn screening (NBS).
Kee Chan   +8 more
doaj   +2 more sources

Parents’ Experiences of Receiving the Initial Positive Newborn Screening (NBS) Result for Cystic Fibrosis and Sickle Cell Disease [PDF]

open access: yesJournal of Genetic Counseling, 2016
The clinical advantages of the newborn screening programme (NBS) in the UK are well described in the literature. However, there has been little exploration of the psychosocial impact on the family. This study followed the principles of grounded theory to
J. Chudleigh   +7 more
semanticscholar   +7 more sources

Analytical Study Showing a False-Negative Limitation of Deletion-Based Newborn Screening for Spinal Muscular Atrophy Using a Compound Heterozygous SMN1 Control [PDF]

open access: yesInternational Journal of Neonatal Screening
Newborn screening (NBS) facilitates the presymptomatic diagnosis and early treatment of spinal muscular atrophy (SMA). An analytical study was conducted to evaluate the performance and limitations of a real-time polymerase chain reaction-based SMA-NBS ...
Yuichi Abe   +7 more
doaj   +2 more sources

Different algorithms for CF newborn screening (NBS): a retrospective evaluation

open access: yesJournal of Cystic Fibrosis, 2010
C. Corbetta   +5 more
semanticscholar   +2 more sources

Sustainability of newborn screening for sickle cell disease in resource-poor countries: A systematic review.

open access: yesPLoS ONE
Sickle cell disease (SCD) is a worldwide genetic blood disorder. Roughly 400,000 babies are born with SCD each year worldwide. More than 75% of these births occur in sub-Saharan Africa.
Chinwe O Okeke   +5 more
doaj   +2 more sources

Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot

open access: yesInternational Journal of Neonatal Screening, 2022
Advancements in therapies for Duchenne muscular dystrophy (DMD) have made diagnosis within the newborn period a high priority. We undertook a consortia approach to advance DMD newborn screening in the United States.
Michael J. Hartnett   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy